Cosmo Pharmaceuticals on Friday reported the renewal of its multi-year manufacturing and supply agreement with Takeda ...

August 8, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced the renewal of its multi-year manufacturing and supply ...

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...

Q2 2025 Earnings Call Transcript August 6, 2025 Mirum Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Mild and moderate infections are common among individuals with IBD and tend to be linked to patient characteristics and treatments.

According to Research by SNS Insider, U.S. Multiple Myeloma Market is projected to reach USD 13.91 Billion by 2032, as novel drug classes, immunotherapies, and diagnostic advances reshape treatment ...

Surgical management, under local anesthesic using lidocaine with epinephrine, involved the plane-by-plane suturing of the tongue with 4/0 absorbable sutures in the lingual muscles (deep structures) ...

A new market analysis projects the global myelodysplastic syndrome (MDS) treatment market will grow from an estimated value ...